COM-701

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameCOM-701
Drug Alias NameCGEN-15029COM-701
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionTransmembrane protein PVRIG antagonists
TargetsTransmembrane protein PVRIG
Therapy Area/IndicationsSolid tumoursEndometrial NeoplasmsLung Neoplasms +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFranceIsrael
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCompugen Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCompugen Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursEndometrial NeoplasmsLung Neoplasms +[8] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A